Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-04-23 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2025-10-30 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-06-12 Disclosures
  • [Disclosure] Celltrion (068270) – Provisional Sales Results / 2024-08-07 Disclosures
  • [Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30 Semiconductors
  • [Disclosure] ISU PETASYS(007660) – Decision on Cash/In-Kind Dividend / 2025-02-12 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-07-28 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the US / 2026-03-12 Disclosures

Category: Disclosures

[Disclosure] Samsung Biologics (207940) – Decision on Debt Guarantee for Others / 2026-03-20

Posted on March 20, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Decision on Debt Guarantee for Others / 2026-03-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has resolved to provide a payment guarantee of approximately KRW 332.9B for the real estate lease agreement of a US entity acquired through its wholly owned US subsidiary. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Changes in…

Read More “[Disclosure] Samsung Biologics (207940) – Decision on Debt Guarantee for Others / 2026-03-20” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Results of Annual General Meeting of Shareholders / 2026-03-20

Posted on March 20, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Results of Annual General Meeting of Shareholders / 2026-03-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has approved all agenda items at its 15th Annual General Meeting of Shareholders, including FY2025 financial statements with KRW 4.56T in revenue, the re-election of Inside Director John Chongbo Rim, and the re-election of Jung Yeon Kim as Outside Director while newly appointing her…

Read More “[Disclosure] Samsung Biologics (207940) – Results of Annual General Meeting of Shareholders / 2026-03-20” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-03-20

Posted on March 20, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-03-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has decided to participate in a rights offering of its U.S. subsidiary (Samsung Biologics America) to acquire 350,000 new shares for approximately KRW 524.9B in cash. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Capital Payment…

Read More “[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-03-20” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Decision on Rights Offering / 2026-03-20

Posted on March 20, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Decision on Rights Offering / 2026-03-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics’ U.S. subsidiary (Samsung Biologics America) has decided on a shareholder-directed rights offering of approximately KRW 524.9B to fund the acquisition of Human Genome Sciences in Rockville, U.S., and cover operating expenses. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Read More “[Disclosure] Samsung Biologics (207940) – Decision on Rights Offering / 2026-03-20” »

Disclosures, Bio & Healthcare

[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-Up Plan / 2026-03-20

Posted on March 20, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-Up Plan / 2026-03-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor disclosed its Corporate Value-Up Plan, highlighting its qualification as a high-dividend corporation, expansion of Advanced Package bonders across the AI semiconductor market, new equipment release roadmaps, and growing demand for EMI shield equipment. 📊 [Key Disclosure Contents & Summary of Major Figures] 📝 Editor’s…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-Up Plan / 2026-03-20” »

Semiconductors, Disclosures

[Disclosure] Samsung Electro-Mechanics (009150) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19

Posted on March 19, 2026July 30, 2026 By K-STOCK Editor
[Disclosure] Samsung Electro-Mechanics (009150) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electro-Mechanics announced its 2026 Corporate Value-up Plan, focusing on high-growth businesses in AI, mobility, and humanoids, executing targeted CAPEX, and maintaining a dividend payout ratio of over 20%. 📊 [Summary of Key Disclosure Facts & Figures] 1. Basic Information 2. Key Highlights (Targets & Action…

Read More “[Disclosure] Samsung Electro-Mechanics (009150) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19” »

Semiconductors, Disclosures

[Disclosure] KEPCO (015760 / KEP) – Serious Industrial Accident / 2026-03-19

Posted on March 19, 2026August 12, 2026 By K-STOCK Editor
[Disclosure] KEPCO (015760 / KEP) – Serious Industrial Accident / 2026-03-19

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO disclosed that a casualty occurred involving an employee of its subsidiary, KEPCO KPS, at a thermal power plant in India, prompting local site verification and countermeasures. 📊 Key Disclosure Content & Financial Highlights • Disclosure Title: Serious Industrial Accident (Major Management Matter…

Read More “[Disclosure] KEPCO (015760 / KEP) – Serious Industrial Accident / 2026-03-19” »

Disclosures, Energy

[Disclosure] Samsung Electronics (005930) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19

Posted on March 19, 2026July 29, 2026 By K-STOCK Editor
[Disclosure] Samsung Electronics (005930) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics unveiled its 2026 Corporate Value-up Plan, committing over KRW 110T in facility and R&D investments in 2026, pursuing M&As in growth sectors, and maintaining shareholder returns based on Free Cash Flow. 📊 [Key Disclosure Contents & Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Read More “[Disclosure] Samsung Electronics (005930) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19” »

Semiconductors, Disclosures

[Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2026-03-19

Posted on March 19, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2026-03-19

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean held its 26th Annual General Meeting of Shareholders, approving all submitted agenda items including consolidated financial statements, articles of incorporation amendments for renewable energy business purposes, the re-appointment of Inside Director Hee-Cheul Kim, and the new appointments of Outside Directors (Audit Committee members) Young-Sam…

Read More “[Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2026-03-19” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary) / 2026-03-19

Posted on March 19, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary) / 2026-03-19

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean’s subsidiary, Hanwha Ocean USA International LLC, has resolved to conduct a paid-in capital increase totaling approximately KRW 164.0B to fund working capital and acquire securities of other corporations. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Capital…

Read More “[Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary) / 2026-03-19” »

Disclosures, Shipbuilding

Posts pagination

Previous 1 … 41 42 43 … 252 Next
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Automotive & AI Server Mix · FC-BGA Supply Ramp · ASP Defense / 2025-04-30 RESEARCH
  • [Disclosure] SK Square (402340) – Decision to Enter into Treasury Stock Trust Agreement / 2025-03-27 Semiconductors
  • [Disclosure] SK square (402340) – Decision on General Shareholders Meeting / 2026-02-24 Semiconductors
  • [Disclosure] SK Square (402340) – Submission of Audit Report / 2024-03-08 Semiconductors
  • [Disclosure] SK Square (402340) – Clarification on Rumors or Reports / 2024-11-06 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Shinhan Securities | Elevated Earnings Visibility · Disciplined Supply · BUY Rating & Target Price Maintained / 2024-04-26 RESEARCH
  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-03-17 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2024-12-17 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme